Tech startup BioOra aims to scale up and democratise blood cancer treatments

Tech startup BioOra aims to scale up and democratise blood cancer treatments
One of the machines BioOra will use to automate CAR-T cell production. (Image: BioOra/Malaghan Institute)
Greg Hurrell
New Zealand tech startup company BioOra is in the business of automating an experimental but laborious cancer therapy process now undergoing clinical trials.BioOra was specifically set up to automate the manufacture of the Malaghan Institute’s individualised treatment for some types of blood cancer.To start with, the automated process will allow more patients to be brought into the trials, but if Medsafe approves the therapy, it is on track to become a standard blood cancer therapy.While BioOra has ambitions to manufacture Malaghan’...

More Health

Minister's $200m tobacco tax cut bypasses Cabinet requirements
Policy

Minister's $200m tobacco tax cut bypasses Cabinet requirements

Researchers say there's more evidence to support the repealed Smokefree policies.

Jem Traylen 26 Jul 2024
Blood cancer clinical trials starting at Wellington Hospital
News in Brief

Blood cancer clinical trials starting at Wellington Hospital

The phase 2 trial will test the Malaghan Institute's groundbreaking therapy.

Staff reporters 25 Jul 2024
Commissioner replaces Te Whatu Ora’s board
Policy

Commissioner replaces Te Whatu Ora’s board

Lester Levy to be new health czar.

Jem Traylen 22 Jul 2024
Health NZ: fewer billion-dollar hospital projects, more staging
Infrastructure

Health NZ: fewer billion-dollar hospital projects, more staging

The centralised agency wants to change how NZ delivers health infrastructure.

Oliver Lewis 18 Jul 2024